News for XCRT Stock
Xcelerate, Inc. Announces Funding
Xcelerate, Inc. Announces the Launch of the Ceramedx Tik Tok Skincare Campaign
Xcelerate, Inc. Issues Shareholder Update
Xcelerate, Inc. Announces Commencement of the Nationalization Process for its PCT International Patent Applications
Xcelerate, Inc. Releases Shareholder Update
Xcelerate, Inc. Retains Investment Bank Craft Capital Management to Provide Investment Banking and Up-Listing Advisory Services
Xcelerate, Inc. Addresses Concerns About Recently Released Research Report
Xcelerate, Inc. Announces Change of Auditors
Xcelerate, Inc. Announces That It Has Filed Its 2023 Annual Report
Xcelerate, Inc. Announces That ESN Group, Inc. Has Gone Live on the Army & Air Force Exchange Service Online Exchange
Xcelerate, Inc. Engages Leading Investor Relations Firm Darrow Associates to Enhance Capital Markets Presence
Xcelerate, Inc. Announces Participation in The Microcap Conference
Xcelerate, Inc. Announces Publication of its Two Utility Patent Applications
Xcelerate, Inc. Announces that ESN Group, Inc. Has Been Approved as a Vendor to Army & Air Force Exchange Service
Xcelerate Announces Marketing Agreement
Xcelerate, Inc. Acquires a Majority Interest in ESN Group
Xcelerate, Inc. Announces Interview With CEO Michael O'Shea
Xcelerate, Inc. Announces PTO and PCT Filings For Surgical Devices
Xcelerate, Inc. Announces Agreement to Acquire a Controlling Interest in ESN, Inc.
Xcelerate Announces that Afya Sasa Signs Agreement with the National Hospital of Tanzania
Fabian Urquijo Joins the Advisory Board of Xcelerate, Inc.
Xcelerate Inc. to Acquire Controlling Interest in ESN Group, Inc
Xcelerate, Inc. Releases Message from CEO
Xcelerate, Inc. to Develop Consumer Healthcare Products
Additional Countries Add Patent Protection
Xcelerate, Inc. Announces Uplisting to OTCQB Market
Xcelerate, Inc. Applies to Trade on the OTCQB Venture Marketplace
Cathy Scangarella to Join the Advisory Board of Xcelerate, Inc.
Wilken, O’Shea Talk Acquisition of HS Pharmaceuticals and What It Means for The Future Of XCRT
Xcelerate, Inc. Announces Appointment of New Board Member
Xcelerate, Inc. Expands IP with Acquisition of Patent Portfolio
Xcelerate, Inc. (OTC Markets: XCRT) Retains SmallCapVoice.com Inc. to Provide Investor Relations Services
SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Michael O’Shea, CEO of Xcelerate, Inc. (OTC Markets: XCRT) and Dr. Dilan Ellegala Xcelerate Advisory Board Member Discussing the Launch of a Pilot Program in Tanzania
Xcelerate, Inc. Files Medical Surgical Device Patent
Thomas E. Mannle, Jr. to Join the Advisory Board of Xcelerate, Inc.
Xcelerate, Inc. Launches Pilot Project in Four African Hospitals
Xcelerate, Inc. CEO Discusses Using AI to Advance Medical Care in Africa in Interview with SmallCapVoice.com
Michael O’Shea CEO, Releases Shareholder Update
Fran White to Join the Advisory Board of Xcelerate, Inc.
Xcelerate Files Supplemental Information For Removal of Shell Status
Xcelerate, Inc. Issues Shareholder Update
Xcelerate Acquires Controlling Interest in AfiyaSasa Africa
Xcelerate, Inc. Signs Definitive Memorandum of Understanding with HS Pharmaceuticals, LLC
Xcelerate Completes Audit of Consolidated Annual Financial Statements
Xcelerate, Inc. Retains Accounting Firm For Audit
Xcelerate, Inc. Announces Investment Banking Agreements for Consulting Services and Acquisition Financing
Dr. Barry Marshall Shares Xcelerate's Mission In Advancing Medical Technology On ticker NEWS' Globally-Streamed Broadcast
Xcelerate, Inc. Signs Letter of Intent to Explore Business Relationship with HS Pharmaceuticals
Xcelerate Inc. Announces Removal of "Yield" Sign on OTC Markets Stock Quotes
Xcelerate, Inc. Unveils Website That Crosses the Divide Between Non-Medical Engineering and Clinical Care
Head of Non-Standard Investments at FinTrust, Vincent C. du Vigneaud, Joins Advisory Board of Xcelerate, Inc.
Xcelerate, Inc. Now Trading Under Ticker Symbol XCRT
Back to Sitemap